Sun Pharmaceuticals Industries Ltd
company logo

Sun Pharmaceuticals Industries Ltd

Sun Pharma.Inds. Share Price

Pharmaceuticals
Large Cap

-

0 (0%)


Start Investing in Sun Pharmaceuticals Industries Ltd

*By signing up you agree to our Terms and Conditions

Sun Pharmaceuticals Industries Ltd Performance

-

-

-

-


-

-

-

-

-

Sun Pharmaceuticals Industries Ltd Fundamentals

4,52,850.48Cr

42.94

7.11

0.08

43.95

0.72%

265.35

i buttonClick here to know more about Fundamentals

Sun Pharmaceuticals Industries Ltd F&O

Sun Pharmaceuticals Industries Ltd Option Chainright-arrow

Sun Pharmaceuticals Industries Ltd Financials

Sun Pharmaceuticals Industries Ltd Financialsright-arrow

Sun Pharmaceuticals Industries Ltd Shareholding Pattern

Sun Pharmaceuticals Industries Ltd Delivery and Volume

About Sun Pharmaceuticals Industries Ltd

Company Overview

Sun Pharmaceutical Industries Ltd. (Sun Pharma), which generates global sales of more than US$ 5.1 billion, is the fourth-largest specialty generic pharmaceutical firm in the world. With the help of more than 40 production facilities, we supply more than 100 nations with

Dilip S Shanghvi

1993

SUNPHARMA

NameDesignation
Dilip S ShanghviChairman & Managing Director
Sudhir V ValiaNon-Exec & Non-Independent Dir
Gautam DoshiNon-Exec. & Independent Dir.
Pawan GoenkaLead Independent Director
Rama BijapurkarIndependent Director
Anoop DeshpandeCompany Sec. & Compli. Officer
Sanjay K AsherIndependent Director
Rolf HoffmannIndependent Director
Aalok ShanghviWhole Time Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Sun Pharmaceuticals Industries Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Sun Pharmaceuticals Industries Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Sun Pharmaceuticals Industries Ltd's share price is ₹1901.95 as of 2024-10-11.
Sun Pharmaceuticals Industries Ltd's P/E ratio is 42.94 times as of 2024-10-11.
Sun Pharmaceuticals Industries Ltd's most recent financial reports indicate a price-to-book ratio of 7.11, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Sun Pharmaceuticals Industries Ltd's market capitalization is ₹452850.48 Cr as on 2024-10-11.
The current financial records of Sun Pharmaceuticals Industries Ltd show a 12.05% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Sun Pharmaceuticals Industries Ltd's most recent financial filings, the company has a total asset value of ₹16739.1, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Sun Pharmaceuticals Industries Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Sun Pharmaceuticals Industries Ltd's 52-week high and low as of 2024-10-11 are ₹1909.35 and ₹1890.5, respectively.